Brazil's ANVISA regulatory agency approved generic semaglutide applications in principle in 2024, with first commercial launches anticipated by 2026 to 2027, which will substantially increase API procurement from cost-competitive generic API suppliers
The operation was performed without any complications, and the patient had an excellent postoperative result
Pair each meal with lean protein, fiber, and healthy fats to support satiety and maintain muscle mass
Metagenomic-based characterization of the gut virome in patients with polycystic ovary syndrome
Think of it like maintaining a water reservoir
Progress will require crosssector dialogue among actuaries, clinicians, PBMs, manufacturers, and policymakers to align coverage, clinical practice, and evidence generationturning therapeutic promise into measurable, equitable value